UK stock alert

UK

CLOSING UPDATE: GlaxoSmithKline decreases further 0.7%, led Pharmaceuticals & biotechnology sector lower 15 June 2018 19:19 BST

NEWS BITES - EUROPE

This is an end of day Alert, produced after today's United Kingdom market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

GlaxoSmithKline, the largest pharmaceuticals & biotechnology company by market capitalisation in the United Kingdom, has decreased 1.5% to trade at GBX1,556.0 vs. the Pharmaceuticals & biotechnology sector which weakened 117.5 points (or 1.7%) to 6,907.7. Representing a weighting of about 37.7% of the sector, the stock accounted for 34.6% of today's loss. Trading volume was 1.7 times average at the end of the day. Compared with the FTSE 100 Index which fell 131.9 points (or 1.7%) in the day, this represented a relative price increase of 0.2%.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

+ Price/Earnings of 49.5 [33.6]

Note

GlaxoSmithKline today is at a discount of 6.9% to the 12-month high of GBX1,670.93 on 22 Jun, 2017. It is at a premium of 28.1% to the 12-month low of GBX1,214.93 on 06 Feb, 2018.

Bullish Signals:

The positive 22.4 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

Tobin's Q Ratio is 1.4. Compared with the rest of the market the stock is undervalued.

Net profit margin has averaged 15.3% in the last 3 years. This is considered superior and suggests a high margin of safety.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

Price/Sales of 2.5 [3.1]

Dividend yield of 2.7% [2.5%]

Return on Capital Employed 14.3% [6.9%]

TODAY'S ALERT

Afternoon Alert: GlaxoSmithKline decreases 0.9%, leads Pharmaceuticals & biotechnology sector lower

15 June 2018 15:54 BST

GlaxoSmithKline PLC (L:GSK) has decreased 0.9% to trade at GBX1,566.60 vs. the Pharmaceuticals & biotechnology sector which weakened 79.5 points (or 1.1%) to 6,945.7. Representing a weighting of about 37.8% of the sector, the stock accounted for 28.8% of today's loss. Trading volume was 1.1 times average so far today.

RECENT ALERTS

CLOSING UPDATE: GlaxoSmithKline lifts 2.3%, led Pharmaceuticals & biotechnology sector higher

14 June 2018 19:09 BST

GlaxoSmithKline, the largest pharmaceuticals & biotechnology company by market capitalisation in the United Kingdom, has lifted 2.3% to trade at GBX1,580.20 vs. the Pharmaceuticals & biotechnology sector which strengthened 114.3 points (or 1.6%) to 7,025.2. Representing a weighting of about 37.7% of the sector, the stock accounted for 51.7% of today's gain. The shares have outperformed 87% of the market in the past week. Trading volume was 1.9 times average at the end of the day. Compared with the FTSE 100 Index which rose 62.1 points (or 0.8%) in the day, this represented a relative price increase of 1.5%.

Afternoon Alert: GlaxoSmithKline lifts 2.3%, leads market higher

14 June 2018 15:50 BST

GlaxoSmithKline PLC (L:GSK) has lifted 2.3% to trade at GBX1,581.20 vs. the FTSE 100 Index which strengthened 41.6 points (or 0.5%) to 7,745.3. Representing a weighting of about 2.4% of the index, the stock accounted for 10.3% of today's gain. The shares have outperformed 88% of the market in the past week. Trading volume was 2.1 times average so far today.

GlaxoSmithKline PLC (L:GSK; LON:GSK; LN:GSK)

ISIN: GB0009252882

PermID: 4295895781

Source: www.BuySellSignals.com